Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2026-02-20 | UBS | Neutral | Neutral | Hold | $18.52 | Tandem Diabetes price target raised to $22 from $17 at UBS | TheFly |
| 2026-02-20 | Bank of America Securities | Neutral | N/A | Upgrade | $24.9 | BofA Securities Upgrades Tandem Diabetes Care (TNDM) to Neu… | StreetInsider |
| 2026-02-20 | Piper Sandler | Neutral | Neutral | Hold | $18.52 | Tandem Diabetes price target raised to $21 from $14 at Pipe… | TheFly |
| 2026-01-09 | Bernstein | Market Perform | Market Perform | Hold | $22.5 | Tandem Diabetes price target raised to $25 from $18 at Bern… | TheFly |
| 2026-01-09 | Goldman Sachs | Neutral | Neutral | Hold | $22.5 | Tandem Diabetes price target raised to $25 from $16 at Gold… | TheFly |
| 2025-12-17 | RBC Capital | Outperform | Outperform | Hold | $22.6 | Tandem Diabetes price target raised to $30 from $25 at RBC … | TheFly |
| 2025-12-11 | Citigroup | Neutral | Neutral | Hold | $21.47 | Citi ups Tandem target, adds 'downside 90-day catalyst watc… | TheFly |
| 2025-10-07 | Citigroup | Neutral | Neutral | Hold | $15.01 | Tandem Diabetes price target raised to $15 from $11 at Citi | TheFly |
| 2025-08-12 | Citigroup | Neutral | Neutral | Upgrade | $10.115 | Tandem Diabetes upgraded to Neutral from Sell at Citi | TheFly |
| 2025-08-11 | Lake Street | Hold | Buy | Downgrade | $10.61 | Tandem Diabetes downgraded to Hold from Buy at Lake Street | TheFly |